Test ID SFLB Influenza Virus B Antibodies, IgG and IgM (Separate Determinations), Serum
Useful For
Diagnosis of recent infection by influenza virus type B when isolation of the organism by culture is unsuccessful
Method Name
Immunofluorescence
Reporting Name
Influenza Virus B Ab, IgG, IgM, SSpecimen Type
SerumPreferred: Serum gel
Acceptable: Red top
Specimen Volume: 0.25 mL
Additional Information:
1. Incidence of influenza virus infections is seasonal in the United States and usually occurs only from November to March.
2. Indicate influenza virus B.
Specimen Minimum Volume
0.15 mL
Specimen Stability Information
Specimen Type | Temperature | Time |
---|---|---|
Serum | Refrigerated (preferred) | 14 days |
Frozen | 14 days |
Clinical Information
Influenza is usually a mild illness of the upper respiratory tract. Involvement of the lower respiratory tract, however, can lead to 4 types of clinical syndromes; physical signs of lower respiratory tract involvement without roentgenographic evidence of pneumonia, influenza complicated by bacterial pneumonia, primary influenza virus pneumonia, and combined influenzal and bacterial pneumonias.
Influenza virus infections are most severe in patients with certain preexisting conditions such as rheumatic heart disease, bronchopulmonary disease, impaired renal function, and diabetes mellitus. Infections can be more severe in elderly patients, pregnant females, and immunocompromised patients.
Influenza virus type B generally produces less severe disease than type A. Outbreaks of influenza type B virus are usually more localized than type A. Both infections occur in the United States between November and March.
Influenza A is susceptible to antiviral activity of amantadine while influenza B is not inhibited by this drug.
Reference Values
IgG: <1:10
IgM: <1:10
Cautions
Influenza virus infections occur exclusively from November through March.
Day(s) Performed
Monday through Friday; 9 a.m.
Report Available
1 dayPerforming Laboratory

Test Classification
This test has been cleared or approved by the U.S. Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
86710 x 2